1. Aviram M, Brox J, Nordoy A. Acute effects of dietary cod liver oil and cream on plasma lipoproteins. Ann.Nutr Metab 1986;30:143-8.
2. Brox JH, Killie JE, Gunnes S, Nordoy A. The effect of cod liver oil and corn oil on platelets and vessel wall in man. Thromb.Haemost. 1981;46:604-11.
3. Brox JH, Killie JE, Osterud B, Holme S, Nordoy A. Effects of cod liver oil on platelets and coagulation in familial hypercholesterolemia (type IIa). Acta Med.Scand. 1983;213:137-44.
4. Vognild E, Elvevoll EO, Brox J et al. Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans. Lipids 1998;33:427-36.
5. Aviram M, Brox J, Nordoy A. Effects of postprandial plasma and chylomicrons on endothelial cells. Differences between dietary cream and cod liver oil. Acta Med.Scand. 1986;219:341-8.
6. Brox J, Olaussen K, Osterud B et al. A long-term seal- and cod liver oil supplementation in hypercholesterolemic subjects. Lipids 2001;36:7-13.
7. Skuladottir GV, Gudmundsdottir E, Olafsdottir E et al. Influence of dietary cod liver oil on fatty acid composition of plasma lipids in human male subjects after myocardial infarction. J Intern.Med. 1990;228:563-8.
8. Schmidt EB, Pedersen JO, Ekelund S, Grunnet N, Jersild C, Dyerberg J. Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis 1989;77:53-7.
9. Shimokawa H, Vanhoutte PM. Dietary cod liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988;78:1421-30.
10. Shimokawa H, Lam JY, Chesebro JH, Bowie EJ, Vanhoutte PM. Effects of dietary supplementation with cod liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation 1987;76:898-905.
11. Burchard HU, Tischendorf FW. The effects of the intake of cod liver oil on the blood lipid level, the lipoprotein profile and bleeding time. Z.Ernahrungswiss. 1989;28:84-91.
12. Gudbjarnason S. Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Intern.Med.Suppl 1989;225:117-28.
13. Gudbjarnason S, Benediktsdottir VE, Skuladottir G. Effects of n-3 polyunsaturated fatty acids on coronary heart disease. Bibl.Nutr Dieta 1989;1-12.
14. Gudbjarnason S, Oskarsdottir G. Modification of fatty acid composition of rat heart lipids by feeding cod liver oil. Biochim.Biophys.Acta 1977;487:10-5.
15. Benediktsdottir VE, Gudbjarnason S. Modification of the fatty acid composition of rat heart sarcolemma with dietary cod liver oil, corn oil or butter. J Mol.Cell Cardiol. 1988;20:141-7.
16. Akpede GO, Omotara BA, Ambe JP. Rickets and deprivation: a Nigerian study. J R.Soc.Health 1999;119:216-22.
17. Wilton P. Cod liver oil, vitamin D and the fight against rickets. CMAJ. 1995;152:1516-7.
18. Requirand P, Gibert P, Tramini P, Cristol JP, Descomps B. Serum fatty acid imbalance in bone loss: example with periodontal disease. Clin Nutr 2000;19:271-6.
19. Watkins BA, Lippman HE, Le Bouteiller L, Li Y, Seifert MF. Bioactive fatty acids: role in bone biology and bone cell function. Prog.Lipid Res. 2001;40:125-48.
20. Sigurdsson G, Franzson L, Steingrimsdottir L, Sigvaldason H. The association between parathyroid hormone, vitamin D and bone mineral density in 70-year-old Icelandic women. Osteoporos.Int. 2000;11:1031-5.
21. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 2000;43:1093-8.
22. Seip M. [Infant nutrition in Norway in the light of recent research]. Tidsskr.Nor Laegeforen. 1991;111:2122-5.
23. Tsutsumi K, Obata Y, Takayama K, Loftsson T, Nagai T. Effect of cod liver oil extract on the buccal permeation of ergotamine tartrate. Drug Dev.Ind.Pharm. 1998;24:757-62.
24. Olafsdottir AS, Wagner KH, Thorsdottir I, Elmadfa I. Fat-Soluble Vitamins in the Maternal Diet, Influence of Cod liver oil Supplementation and Impact of the Maternal Diet on Human Milk Composition. Ann.Nutr Metab 2001;45:265-72.
25. Semba RD. Vitamin A as "anti-infective" therapy, 1920-1940. J Nutr 1999;129:783-91.
26. Lombardo YB, Chicco A, D'Alessandro ME, Martinelli M, Soria A, Gutman R. Dietary fish oil normalize dyslipidemia and glucose intolerance with unchanged insulin levels in rats fed a high sucrose diet. Biochim.Biophys.Acta 1996;1299:175-82.
27. Chicco A, D'Alessandro ME, Karabatas L, Gutman R, Lombardo YB. Effect of moderate levels of dietary fish oil on insulin secretion and sensitivity, and pancreas insulin content in normal rats. Ann.Nutr Metab 1996;40:61-70.
28. Shimizu H, Ohtani K, Tanaka Y, Sato N, Mori M, Shimomura Y. Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients. Diabetes Res.Clin Pract. 1995;28:35-40.
29. Jensen T, Stender S, Goldstein K, Holmer G, Deckert T. Partial normalization by dietary cod liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. N.Engl.J Med. 1989;321:1572-7.
30. Schimke E, Hildebrandt R, Beitz J et al. Influence of a cod liver oil diet in diabetics type I on fatty acid patterns and platelet aggregation. Biomed.Biochim.Acta 1984;43:S351-S353.
31. Beitz J, Schimke E, Liebaug U et al. Influence of a cod liver oil diet in healthy and insulin-dependent diabetic volunteers on fatty acid pattern, inhibition of prostacyclin formation by low density lipoprotein (LDL) and platelet thromboxane. Klin.Wochenschr. 1986;64:793-9.
32. Codde JP, McGowan HM, Vandongen R, Beilin LJ. Changes in prostanoid synthesis in response to diet and hypertension in one-kidney, one clip rats. Hypertension 1985;7:886-92.
33. Codde JP, Beilin LJ. Dietary fish oil prevents dexamethasone induced hypertension in the rat. Clin Sci.(Lond) 1985;69:691-9.
34. Moritz V, Singer P, Forster D, Berger I, Massow S. Changes of blood pressure in spontaneously hypertensive rats dependent on the quantity and quality of fat intake. Biomed.Biochim.Acta 1985;44:1491-505.
35. Singer P, Berger I, Gerhard U, Wirth M, Moritz V, Forster D. Changes of N-6 and N-3 fatty acids in spontaneously hypertensive (SHR) and normotensive rats after diets supplemented with alpha-linolenic or eicosapentaenoic acids. Prostaglandins Leukot.Med. 1987;28:183-93.
36. Mancino M, Ohia E, Kulkarni P. A comparative study between cod liver oil and liquid lard intake on intraocular pressure on rabbits. Prostaglandins Leukot.Essent.Fatty Acids 1992;45:239-43.
37. Vilaseca J, Salas A, Guarner F, Rodriguez R, Martinez M, Malagelada JR. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 1990;31:539-44.
38. Guarner F, Vilaseca J, Malagelada JR. Dietary manipulation in experimental inflammatory bowel disease. Agents Actions 1992;Spec No:C10-C14.
39. Terkelsen LH, Eskild-Jensen A, Kjeldsen H, Barker JH, Hjortdal VE. Topical application of cod liver oil ointment accelerates wound healing: an experimental study in wounds in the ears of hairless mice. Scand.J Plast.Reconstr.Surg.Hand Surg. 2000;34:15-20.
40. Eriksen W, Sandvik L, Bruusgaard D. Does dietary supplementation of cod liver oil mitigate musculoskeletal pain? Eur.J Clin Nutr 1996;50:689-93.
41. Lips P. Vitamin D deficiency in a multicultural setting. Ned.Tijdschr.Geneeskd. 2001;145:2060-2.
42. Simonsen T, Nordoy A, Sjunneskog C, Lyngmo V. The effect of cod liver oil in two populations with low and high intake of dietary fish. Acta Med.Scand. 1988;223:491-8.
43. Simonsen T, Nordoy A. Ischaemic heart disease, serum lipids and platelets in Norwegian populations with traditionally low or high fish consumption. J Intern.Med.Suppl 1989;225:83-9.
44. Luley C, Klein B, Hanisch M, Prellwitz W. Fatty acid composition and degree of peroxidation in fish oil and cod liver oil preparations.Arzneimittel-forschung. 1988;38:1783-6.
45. Bjerve KS. n-3 fatty acid deficiency in man. J Intern.Med.Suppl 1989;225:171-5.
46. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N.Engl.J Med. 1995;333:1369-73.
47. Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology. Drugs 1997;53:358-88.
48. Die-Smulders CE, Sturkenboom MC, Veraart J, van Katwijk C, Sastrowijoto P, van der LE. Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy. Teratology 1995;52:215-9.
49. Mills CM, Marks R. Adverse reactions to oral retinoids. An update. Drug Saf 1993;9:280-90.
50. Heckel S, Favre R, Weber P, Dellenbach P. [Teratogenicity of retinoids. A case and review of the literature]. J Gynecol.Obstet.Biol.Reprod.(Paris) 1993;22:43-7.
51. Nau H. Embryotoxicity and teratogenicity of topical retinoic acid. Skin Pharmacol. 1993;6 Suppl 1:35-44.
52. Pinnock CB, Alderman CP. The potential for teratogenicity of vitamin A and its congeners. Med.J Aust. 1992;157:804-9.
53. Miller RK, Hendrickx AG, Mills JL, Hummler H, Wiegand UW. Periconceptional vitamin A use: how much is teratogenic? Reprod.Toxicol. 1998;12:75-88.
54. Wiegand UW, Hartmann S, Hummler H. Safety of vitamin A: recent results. Int.J Vitam.Nutr Res. 1998;68:411-6.
55. Knapp HR and others. The Effect of Cod liver oil on the Development of Atherosclerosis in an Animal Model. Proceedings of the AOCS, Ed WEM Lands, AOCS 1987, pp 35-40.
56. Shu XO and others. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988 Aug 1;62(3):635-44.
57. Veierod MG, Laake P, Thelle DS. Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev 1997 Dec;6(6):540-9. |